Evidence map›Paper›PMID 31109098›Full record

ArticlePharmaceuticals (Basel, Switzerland)2019

Magnetic Graphene Oxide Nanocarrier for Targeted Delivery of Cisplatin: A Perspective for Glioblastoma Treatment.

Sami A Makharza, Giuseppe Cirillo, Orazio Vittorio, Emanuele Valli, Florida Voli, Annafranca Farfalla, Manuela Curcio, Francesca Iemma, Fiore Pasquale Nicoletta, Ahmed A El-Gendy and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Special Issue "Anticancer Drugs".Pharmaceuticals (Basel, Switzerland) · 2019
    Article
  11. Synthesis of Graphene Oxide-FeInternational journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 6 countries.

Sami A MakharzaLeibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany. samim@hebron.edu.ORCID 0000-0001-7980-3399
Giuseppe CirilloLeibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany. giuseppe.cirillo@unical.it.
Orazio VittorioChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2031, Australia. OVittorio@ccia.org.au.
Emanuele ValliChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2031, Australia. EValli@ccia.org.au.ORCID 0000-0002-0928-8624
Florida VoliChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2031, Australia. FVoli@ccia.org.au.
Annafranca FarfallaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (CS), 87036 Rende, Italy. annafranca.farfalla@gmail.com.
Manuela CurcioDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (CS), 87036 Rende, Italy. manuela.curcio@unical.it.
Francesca IemmaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (CS), 87036 Rende, Italy. francesca.iemma@unical.it.
Fiore Pasquale NicolettaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (CS), 87036 Rende, Italy. fiore.nicoletta@unical.it.ORCID 0000-0001-5961-1963
Ahmed A El-GendyDepartment of Physics, University of Texas at El Paso, El Paso, TX 79968, USA. aelgendy@utep.edu.ORCID 0000-0001-7212-6647
Gerardo F GoyaInstitute of Nanoscience of Aragon (INA) & Department of Condensed Matter Physics, University of Zaragoza, 50018 Zaragoza, Spain. goya@unizar.es.ORCID 0000-0003-1558-9279
Silke HampelLeibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany. s.hampel@ifw-dresden.de.ORCID 0000-0003-3346-8446
University of Calabria · ITCancer Institute of New South Wales · AULeibniz Institute for Solid State and Materials Research · DEHebron University · PSThe University of Texas at El Paso · USUniversidad de Zaragoza · ESUniversity of Technology Sydney · AU

Funding

META ANALYSIS OF RISK FACTORS FOR PROSTATE CANCERR03CA078201 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI DENNIS, LESLIE K · 1998 to 1998
–
Aragon Regional Government E26DAAD Re-invitation Programme for Former Scholarship Holders, 2018 57378442Spanish Ministerio de Ciencia, Innovación y Universidades MAT2016-78201-P
6 · The paper itself

Abstract

Selective vectorization of Cisplatin (CisPt) to Glioblastoma U87 cells was exploited by the fabrication of a hybrid nanocarrier composed of magnetic γ-Fe

Indexed as

cisplatinglioblastomagraphene oxidemaghemitemagnetic targeting

Identifiers

PMID31109098
PMCPMC6631527
OpenAlexW2946376618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.